[EN] ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF<br/>[FR] DÉRIVÉS AMINOESTER D'ALCALOÏDES ET COMPOSITIONS MÉDICINALES LES COMPRENANT
申请人:CHIESI FARMA SPA
公开号:WO2011161018A1
公开(公告)日:2011-12-29
The present invention relates to alkaloid aminoester derivatives acting as muscarinic receptor antagonists, processes for their preparation, compositions comprising them and therapeutic uses thereof.
[EN] TACHYKININ RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DU RECEPTEUR TACHYKININE
申请人:LILLY CO ELI
公开号:WO2005000821A1
公开(公告)日:2005-01-06
The present invention relates to selective NK-1 receptor antagonists of Formula (I) or a pharmaceutically acceptable salt thereof, for the treatment of disorders associated with an excess of tachykinins.
Synthesis of isomeric 2,3,5-trisubstituted perhydropyrrolo[3,4-d]-isoxazole-4,6-diones via 1,3-dipolar cycloaddition reactions
作者:Hamdi Özkan、Yilmaz Yildirir
DOI:10.1002/jhet.395
日期:——
A series of isoxazolidine derivates (isomeric 2,3,5‐trisubstitutedperhydropyrrolo[3,4‐d]isoxazole‐4,6‐diones) used as anti‐inflammatory, immunosuppressive, antibacterial agent, and inhibitor for some enzymes were synthesized. These compounds were prepared by 1,3‐dipolar cycloaddition of N‐methyl maleimide and N‐phenyl maleimide with nitrones. Diastereomeric products obtained in this reaction were separated
合成了一系列异恶唑烷衍生物(2,3,5-三取代的全氢吡咯并[3,4-d]异恶唑-4,6-二酮异构体),用作抗炎药,免疫抑制剂,抗菌剂和某些酶的抑制剂。这些化合物是通过将N-甲基马来酰亚胺和N-苯基马来酰亚胺与硝酮进行1,3-偶极环加成制备的。通过柱色谱分离在该反应中获得的非对映异构体产物并重结晶。通过元素分析和光谱方法(1 H NMR,13 C NMR和FTIR)对所有合成的化合物进行表征。J.杂环化学。(2010)。
[EN] AZAINDAZOLES<br/>[FR] AZAINDAZOLES
申请人:GLAX0SMITHKLINE LLC
公开号:WO2013039988A1
公开(公告)日:2013-03-21
Herein are disclosed azaindazoles of formula (I), (I), where the various groups are defined herein, and which are useful for treating cancer.
To identify new highly selective EP4-agonists, further modification of the 16-phenyl moiety of 1 was continued. 16-(3-methoxymethyl)phenyl derivatives 13-(6q) and 16-(3-ethoxymethyl)phenyl derivatives 13-(7e) showed more selectivity and potent agonist activity than 1. 16-(3-methyl-4-hydroxy)phenyl derivative 18-(14e) demonstrated excellent subtype selectivity, while both its receptor affinity and agonist